HER3-binding proteins and their uses

TW202635737APending Publication Date: 2026-09-01BEIJING TIDE PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101439
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-16
Filing Date
2026-01-14
Publication Date
2026-09-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

This application provides HER-binding proteins and their uses. Specifically, it provides antibodies against HER3 or antigen-binding fragments thereof, nucleic acid molecules encoding them, and methods for their preparation. The HER3 antibodies or antigen-binding fragments thereof exhibit stronger binding to human HER3 protein and / or tumor cells expressing human HER3 protein compared to the positive control antibody BMK1. Further, it provides the use of the antibodies or antigen-binding fragments thereof in the treatment and diagnosis of diseases.
Need to check novelty before this filing date? Find Prior Art